Pfizer

News

FDA has approved the 2026 COVID vaccine formulations, but last year's narrower recommendation stands, leaving open questions about access.

News

Pfizer is creating the role of AI Scholar for computational biologist Eric Schadt, who is leaving Pathos AI to start a new stealth venture.

News

After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU.

News

Pfizer's second-quarter results update is headlined by news of an additional $2.5 billion in cost-cutting initiatives.

News

Pfizer's JAK inhibitor Litfulo hits the mark in vitiligo, setting up filings, as Incyte claims EU approval for Opzelura in atopic dermatitis.

News

The House China Select Committee has quizzed MSD, AbbVie, Bristol Myers Squibb, and Pfizer about the ethics of clinical trials run in China.